Ischemic limb gangrene with pulses

New England Journal of Medicine

Volumn 373, Issue 7, 2015, Pages 642-655

  Warkentin, Theodore E ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON REGIONAL LABORATORY MEDICINE PROGRAM   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; HEPARIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; THROMBOMODULIN; TUMOR NECROSIS FACTOR ALPHA; WARFARIN;

ACUTE HEPATITIS; ACUTE ISCHEMIC HEPATITIS; ADENOCARCINOMA; CALCINOSIS; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; DOWN REGULATION; ERGOTISM; ESCHERICHIA COLI; FASCIOTOMY; FEVER; FIBRIN DEPOSITION; FROSTBITE; FULMINATING PURPURA; GANGRENE; HAEMOPHILUS INFLUENZAE; HEPARIN INDUCED THROMBOCYTOPENIA; HISTOPATHOLOGY; HUMAN; HYPOTENSION; INTERNATIONAL NORMALIZED RATIO; LEG THROMBOSIS; LIMB AMPUTATION; LIMB ISCHEMIA; LYMPHOPROLIFERATIVE DISEASE; MENINGOCOCCEMIA; MICROTHROMBUS; MULTIPLE ORGAN FAILURE; NEISSERIA MENINGITIDIS; PARTIAL THROMBOPLASTIN TIME; PETECHIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULSE WAVE; RAYNAUD PHENOMENON; REVIEW; SKIN NECROSIS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOTIC THROMBOCYTOPENIC PURPURA; VASCULITIS; VENOUS LIMB GANGRENE; WOUND CARE; COMPLICATION; LIMB; MICROBIOLOGY; MICROCIRCULATION; PATHOLOGY; PULSE RATE; VASCULARIZATION; VEIN THROMBOSIS;

DIAGNOSIS, DIFFERENTIAL; DISSEMINATED INTRAVASCULAR COAGULATION; EXTREMITIES; GANGRENE; HUMANS; MICROCIRCULATION; PULSE; VENOUS THROMBOSIS;

EID: 84941729325     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMra1316259     Document Type: Review

References (77)

1. Warkentin TE, Cook RJ, Sarode R, Sloane DA, Crowther MA. Warfarin-induced venous limb ischemia/gangrene complicating cancer: a novel and clinically distinct syndrome. Blood 2015; 126: 486-93.
2. Warkentin TE, Elavathil LJ, Hayward CPM, Johnston MA, Russett JI, Kelton JG. The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia. Ann Intern Med 1997; 127: 804-12.
3. Molos MA, Hall JC. Symmetrical peripheral gangrene and disseminated intravascular coagulation. Arch Dermatol 1985; 121: 1057-61.
4. Ghosh SK, Bandyopadhyay D, Ghosh A. Symmetrical peripheral gangrene: a prospective study of 14 consecutive cases in a tertiary-care hospital in eastern India. J Eur Acad Dermatol Venereol 2010; 24: 214-8.
5. Barraud S. Über Extremitätengangrän im jugendlichen Alter nach Infektionskrankheiten. Dtsch Z Chir 1904; 74: 237-97.
6. Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999; 341: 586-92.
7. Gando S. Microvascular thrombosis and multiple organ dysfunction syndrome. Crit Care Med 2010; 38: Suppl: S35-S42.
8. Levi M, Van Der Poll T. Thrombomodulin in sepsis. Minerva Anestesiol 2013; 79: 294-8.
9. Warkentin TE, Hayward CPM, Boshkov LK, et al. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparininduced thrombocytopenia. Blood 1994; 84: 3691-9.
10. Geddings JE, Mackman N. Tumorderived tissue factor-positive microparticles and venous thrombosis in cancer patients. Blood 2013; 122: 1873-80.
11. Esmon CT. The protein C pathway. Chest 2003; 124: Suppl: 26S-32S.
12. Haimovici H. The ischemic forms of venous thrombosis. 1. Phlegmasia cerulea dolens. 2. Venous gangrene. J Cardiovasc Surg (Torino) 1965; 5: Suppl: 164-73.
13. Perkins JMT, Magee TR, Galland RB. Phlegmasia caerulea dolens and venous gangrene. Br J Surg 1996; 83: 19-23.
14. Warkentin TE. Venous limb gangrene during warfarin treatment of cancer-associated deep venous thrombosis. Ann Intern Med 2001; 135: 589-93.
15. Srinivasan AF, Rice L, Bartholomew JR, et al. Warfarin-induced skin necrosis and venous limb gangrene in the setting of heparin-induced thrombocytopenia. Arch Intern Med 2004; 164: 66-70.
16. Grim Hostetler S, Sopkovich J, Dean S, Zirwas M. Warfarin-induced venous limb gangrene. J Clin Aesthet Dermatol 2012; 5: 38-42.
17. Padjas A, Brzezinska-Kolarz B, Undas A, Musial J. Phlegmasia cerulea dolens as a complication of deep vein thrombosis in a man with primary antiphospholipid syndrome. Blood Coagul Fibrinolysis 2005; 16: 567-9.
18. Bell WR, Starksen NF, Tong S, Porterfield JK. Trousseau's syndrome: devastating coagulopathy in the absence of heparin. Am J Med 1985; 79: 423-30.
19. Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 2001; 344: 1286-92.
20. Warkentin TE. Agents for the treatment of heparin-induced thrombocytopenia. Hematol Oncol Clin North Am 2010; 24: 755-75.
21. Warkentin TE, Greinacher A, Koster A, Lincoff AM. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 2008; 133: 6 Suppl: 340S-380S.
22. Warkentin TE. Heparin-induced thrombocytopenia in critically ill patients. Semin Thromb Hemost 2015; 41: 49-60.
23. Vadivel K, Schmidt AE, Marder VJ, Krishnaswamy S, Bajaj SP. Structure and function of vitamin K-dependent coagulant and anticoagulant proteins. In: Marder VJ, Aird WC, Bennett JS, Schulman S, White GC, eds. Hemostasis and thrombosis: basic principles and clinical practice. 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2013: 208-32.
24. Cole MS, Minifee PK, Wolma FJ. Coumarin necrosis - a review of the literature. Surgery 1988; 103: 271-7.
25. Warkentin TE. Coumarin-induced skin necrosis and venous limb gangrene. In: Marder VJ, Aird WC, Bennett JS, Schulman S, White GC, eds. Hemostasis and thrombosis: basic principles and clinical practice. 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2013: 1308-17.
26. Linkins LA, Dans AL, Moores LK, et al. Treatment and prevention of heparininduced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012; 141: Suppl 2: e495S-e530S.
27. Lee AY, Levine MN, Baker RI, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 2003; 349: 146-53.
28. Rice L. A clinician's perspective on heparin-induced thrombocytopenia: paradoxes, myths, and continuing challenges. In: Warkentin TE, Greinacher A, eds. Heparin-induced thrombocytopenia. 5th ed. Boca Raton, FL: CRC Press, 2013: 608-17.
29. Weaver FA, Meacham PW, Adkins RB, Dean RH. Phlegmasia cerulea dolens: therapeutic considerations. South Med J 1988; 81: 306-12.
30. Warkentin TE. Anticoagulant failure in coagulopathic patients: PTT confounding and other pitfalls. Expert Opin Drug Saf 2014; 13: 25-43.
31. Greinacher A. Heparin-induced thrombocytopenia. N Engl J Med 2015; 373: 252-61.
32. Smythe MA, Warkentin TE, Stephens JL, Zakalik D, Mattson JC. Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin-induced thrombocytopenia. Am J Hematol 2002; 71: 50-2.
33. Qvarfordt P, Eklöf B, Ohlin P. Intramuscular pressure in the lower leg in deep vein thrombosis and phlegmasia cerulae dolens. Ann Surg 1983; 197: 450-3.
34. Meissner MH. Rationale and indications for aggressive early thrombus removal. Phlebology 2012; 27: Suppl 1: 78-84.
35. Erdoes LS, Ezell JB, Myers SI, Hogan MB, LeSar CJ, Sprouse LR II. PharmacoThe mechanical thrombolysis for phlegmasia cerulea dolens. Am Surg 2011; 77: 1606-12.
36. Knight TT Jr, Gordon SV, Canady J, Rush DS, Browder W. Symmetrical peripheral gangrene: a new presentation of an old disease. Am Surg 2000; 66: 196-9.
37. Reinstein L, Govindan S. Extremity amputation: disseminated intravascular coagulation syndrome. Arch Phys Med Rehabil 1980; 61: 97-102.
38. Warner PM, Kagan RJ, Yakuboff KP, et al. Current management of purpura fulminans: a multicenter study. J Burn Care Rehabil 2003; 24: 119-26.
39. Robboy SJ, Mihm MC, Colman RW, Minna JD. The skin in disseminated intravascular coagulation: prospective analysis of thirty-six cases. Br J Dermatol 1973; 88: 221-9.
40. Hamdy RC, Babyn PS, Krajbich JI. Use of bone scan in management of patients with peripheral gangrene due to fulminant meningococcemia. J Pediatr Orthop 1993; 13: 447-51.
41. Watanabe T, Imamura T, Nakagaki K, Tanaka K. Disseminated intravascular coagulation in autopsy cases: its incidence and clinicopathologic significance. Pathol Res Pract 1979; 165: 311-22.
42. Shimamura K, Oka K, Nakazawa M, Kojima M. Distribution patterns of microthrombi in disseminated intravascular coagulation. Arch Pathol Lab Med 1983; 107: 543-7.
43. Fox B. Disseminated intravascular coagulation and the Waterhouse-Friderichsen syndrome. Arch Dis Child 1971; 46: 680-5.
44. Betrosian AP, Berlet T, Agarwal B. Purpura fulminans in sepsis. Am J Med Sci 2006; 332: 339-45.
45. Childers BJ, Cobanov B. Acute infectious purpura fulminans: a 15-year retrospective review of 28 consecutive cases. Am Surg 2003; 69: 86-90.
46. Kirkland KB, Marcom PK, Sexton DJ, Dumler JS, Walker DH. Rocky Mountain spotted fever complicated by gangrene: report of six cases and review. Clin Infect Dis 1993; 16: 629-34.
47. Kato Y, Ohnishi K, Sawada Y, Suenaga M. Purpura fulminans: an unusual manifestation of severe falciparum malaria. Trans R Soc Trop Med Hyg 2007; 101: 1045-7.
48. Chen CF, Wang JL, Wei YF. Symmetrical peripheral gangrene, an uncommon complication of tuberculosis. QJM 2012; 105: 279-80.
49. Wynne JM, Williams GL, Ellman BA. Gangrene of the extremities in measles. S Afr Med J 1977; 52: 117-21.
50. Christiansen CB, Berg RM, Plovsing RR, Møller K. Two cases of infectious purpura fulminans and septic shock caused by Capnocytophaga canimorsus transmitted from dogs. Scand J Infect Dis 2012; 44: 635-9.
51. Brandtzaeg P, Sandset PM, Joø GB, Ovstebø R, Abildgaard U, Kierulf P. The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic pathway inhibitor and fibrinopeptide A in systemic meningococcal disease. Thromb Res 1989; 55: 459-70.
52. Hellum M, Øvstebø R, Brusletto BS, Berg JP, Brandtzaeg P, Henriksson CE. Microparticle-associated tissue factor activity correlates with plasma levels of bacterial lipopolysaccharides in meningococcal septic shock. Thromb Res 2014; 133: 507-14.
53. Fijnvandraat K, Derkx B, Peters M, et al. Coagulation activation and tissue necrosis in meningococcal septic shock: severely reduced protein C levels predict a high mortality. Thromb Haemost 1995; 73: 15-20.
54. Kondaveeti S, Hibberd ML, Booy R, Nadel S, Levin M. Effect of the Factor V Leiden mutation on the severity of meningococcal disease. Pediatr Infect Dis J 1999; 18: 893-6.
55. Siegal DM, Cook RJ, Warkentin TE. Acute hepatic necrosis and ischemic limb necrosis. N Engl J Med 2012; 367: 879-81.
56. Colak T, Erdogan O, Yerebakan O, Arici C, Gurkan A. Symmetrical peripheral gangrene and dopamine. Ulus Travma Acil Cerrahi Derg 2003; 9: 222-4.
57. Hayes MA, Yau EHS, Hinds CJ, Watson JD. Symmetrical peripheral gangrene: association with noradrenaline administration. Intensive Care Med 1992; 18: 433-6.
58. Kalajian AH, Turpen KB, Donovan KO, Malone JC, Callen JP. Phenylephrineinduced microvascular occlusion syndrome in a patient with a heterozygous factor V Leiden mutation. Arch Dermatol 2007; 143: 1314-7.
59. Sharma BD, Kabra SR, Gupta B. Symmetrical peripheral gangrene. Trop Doct 2004; 34: 2-4.
60. Hotchkiss R, Marks T. Management of acute and chronic vascular conditions of the hand. Curr Rev Musculoskelet Med 2014; 747-52.
61. Wollina U, Hansel G, Gruner M, Schönlebe J, Heinig B, Köstler E. Painful ANA-positive scleroderma-like disease with acral ulcerations: a case of chronic gangrenous ergotism. Int J Low Extrem Wounds 2007; 6: 148-52.
62. Hammadah M, Chaturvedi S, Jue J, et al. Acral gangrene as a presentation of non-uremic calciphylaxis. Avicenna J Med 2013; 3: 109-11.
63. Chang JC, Ikhlaque N. Peripheral digit ischemic syndrome can be a manifestation of postoperative thrombotic thrombocytopenic purpura. Ther Apher Dial 2004; 8: 413-8.
64. Sharif M, Hameed S, Akin I, Natarajan U. HIV diagnosis in a patient presenting with vasculitis. Int J STD AIDS 2015.
65. Ames PRJ, Walker E, Aw D, Marshall D, de Villiers F, Staber M. Multi-organ failure in adult onset Still's disease: a septic disguise. Clin Rheumatol 2009; 28: Suppl 1: S3-S6.
66. Grob JJ, Bonerandi JJ. Thrombotic skin disease as a marker of the anticardiolipin syndrome: livedo vasculitis and distal gangrene associated with abnormal serum antiphospholipid activity. J Am Acad Dermatol 1989; 20: 1063-9.
67. Bhoola PH, Shtofmakher G, Bahri A, Patel AA, Barlizo SR, Trepal M. Pedal gangrenous changes in the digits of an adolescent with ulcerative colitis: a case report. J Foot Ankle Surg 2014.
68. Smith OP, White B. Infectious purpura fulminans: diagnosis and treatment. Br J Haematol 1999; 104: 202-7.
69. Piccin A, O'Marcaigh A, McMahon C, et al. Non-activated plasma-derived PC improves amputation rate of children undergoing sepsis. Thromb Res 2014; 134: 63-7.
70. Vincent JL, Ramesh MK, Ernest D, et al. A randomized, double-blind, placebocontrolled, phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation. Crit Care Med 2013; 41: 2069-79.
71. Wada H, Thachil J, Di Nisio M, et al. Guidance for diagnosis and treatment of disseminated intravascular coagulation from harmonization of the recommendations from three guidelines. J Thromb Haemost 2013; 11: 761-7.
72. Zarychanski R, Abou-Setta AM, Kanji S, et al. The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis. Crit Care Med 2015; 43: 511-8.
73. Ranieri VM, Thompson BT, Barie PS, et al. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 2012; 366: 2055-64.
74. Warren BL, Eid A, Singer P, et al. Caring for the critically ill patient: high-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 2001; 286: 1869-78.
75. Kienast J, Juers M, Wiedermann CJ, et al. Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J Thromb Haemost 2006; 4: 90-7.
76. Price VE, Ledingham DL, Krümpel A, Chan AK. Diagnosis and management of neonatal purpura fulminans. Semin Fetal Neonatal Med 2011; 16: 318-22.
77. Josephson C, Nuss R, Jacobson L, et al. The varicella-autoantibody syndrome. Pediatr Res 2001; 50: 345-52.